Form EFFECT CATALYST PHARMACEUTICALS

July 17, 2026 6:03 AM

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	July 16, 2026

Accession Number:

0001193125-26-305098

Submission Type:

POS AM

CIK:	0001369568
Company Name:	CATALYST PHARMACEUTICALS, INC.
File Number:	333-215315

StreetInsider